A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis
Miaofen G. Hu(Tufts University), Philip W. Hinds(Tufts University), Elisabeth A. Hinds(Tufts Medical Center), Daqin Mao(Tufts Medical Center), Miriam Enos(Tufts Medical Center), Rui Chang(Brigham and Women's Hospital), Guo‐fu Hu(Northeast Agricultural University), Amit Deshpande(University of Delaware), Fotini Gounari(WinnMed), Philip N. Tsichlis(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Zhuyan Guo(United States Military Academy), Changchuin Mao(Antagen Pharmaceuticals (United States)), Marei Dose(Tufts Medical Center)
Cited by 115
Related Papers
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
|Cancer Research|2009|1.1k
Angiogenin cleaves tRNA and promotes stress-induced translational repression
|The Journal of Cell Biology|2009|965
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
|Proceedings of the National Academy of Sciences|1997|526
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway
|Journal of Biological Chemistry|1998|512
Copper stimulates proliferation of human endothelial cells under culture
|Journal of Cellular Biochemistry|1998|423